Johnson & Johnson reported $24.6 billion in sales for the fourth quarter of 2025, up 9.1% from the previous year. On an earnings call with investors, the company's CEO sang the praises of the company's cardiovascular health division.

2026 may be the year that many if not most healthcare leaders arrive at a fork in the road to mature AI implementation. 

The bill announced by two Democratic members of the state House of Representatives would guarantee coverage to everyone in the commonwealth—but many of the details have yet to be revealed. 

Where have the missing rural American hospitals gone? And where is rural healthcare headed? The discussion is on in Washington and elsewhere.  

The health system said it offered a “historic” 21.5% raise as part of a new contract, but it’s been unable to reach an agreement with union officials. Workers are expected to walk off the job starting Jan. 26. 

Traditional fee-for-service Medicare saw a slight dip in improper payments, which are usually associated with documentation errors and now outright fraud. CMS also released data on Medicaid and the CHIP program. 

The Missouri complaint mirrors those brought by the Federal Trade Commission, the state of Texas and Philadelphia-based Jefferson Health, among others, in that it’s focused on alleged collusion between pharmacy benefit managers and drug companies to control the price of insulin. 

Cardiology has been shifting from reactionary treatment strategies to a greater emphasis on prevention. This is an especially important trend in heart failure, which is associated with high costs and rising hospitalization rates.